New knee implant tested for Long-Term success

NCT ID NCT02380092

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study follows 163 people who received a LEGION knee replacement with a special VERILAST bearing surface to treat degenerative joint disease. Researchers track how long the implant lasts and how well patients function over time. The goal is to see if this newer device performs as well as or better than an older model.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
LEGION Primary Total Knee System with VERILAST bearing surface (a knee replacement device)
What this could lead to
If successful, this could confirm that the LEGION knee system is a safe and durable option for people needing knee replacement due to arthritis.
What could go wrong
This is a post-market study, not a new treatment. Results may not show major improvement over existing options, and some patients may still need revision surgery.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DEGENERATIVE JOINT DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • AMEOS Klinikum Seepark Geestland

    Langen, Kreis Geestland, 27607, Germany

  • CaritasKlinikum St. Joseph Saarbrücken-Dudweiler

    Saarbrücken-Dudweiler, 66125, Germany

  • Evangelisches Krankenhaus Wien

    Vienna, 1180, Austria

  • KniePraxis Prof. Dr. Tibesku

    Straubing, 94315, Germany

  • OrthoCentrum

    Hamburg, 20149, Germany

  • Orthopadische Krankenhaus Gersthof

    Vienna, 1180, Austria

  • Servicio de C.O.T. Hospital Clínico Universitario de Santiago de Compostela

    Santiago de Compostela, 15706, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.